A recent meta-analysis of selected randomized clinical trials (RCTs), in which population groups of differing ages and health status were supplemented with various doses of b-carotene, vitamin A, and/or vitamin E, found that these interventions increased all-cause mortality. However, this meta-analysis did not consider the rationale of the constituent RCTs for antioxidant supplementation, none of which included mortality as a primary outcome. As the rationale for these trials was to test the hypothesis of a potential benefit of antioxidant supplementation, an alternative approach to a systematic evaluation of these RCTs would be to evaluate this outcome relative to the putative risk of greater total mortality. Thus, we examined these data based on the primary outcome of the 66？RCTs included in the meta-analysis via a decision analysis to identify whether the results provided a positive ( i.e., benefit), null or negative ( i.e., harm) outcome. Our evaluation indicated that of these RCTs, 24 had a positive outcome, 39 had a null outcome, and 3 had a negative outcome. We further categorized these interventions as primary (risk reduction in healthy populations) or secondary (slowing pathogenesis or preventing recurrent events and/or cause-specific mortality) prevention or therapeutic (treatment to improve quality of life, limit complications, and/or provide rehabilitation) studies, and determined positive outcomes in 8 of 20 primary prevention studies, 10 of 34 secondary prevention studies, and 6 out of 16 therapeutic studies. Seven of the eight RCTs with a positive outcome in primary prevention included participants in a population where malnutrition is frequently described. These results suggest that analyses of potential risks from antioxidant supplementation should be placed in the context of a benefit/risk ratio.
References
[1]
Enstrom, J.E.; Kanim, L.E.; Klein, M.A. Vitamin C intake and mortality among a sample of the United States population. Epidemiology？1992, 3, 194–202.
[2]
Knekt, P.; Ritz, J.; Pereira, M.A.; O'Reilly, E.J.; Augustsson, K.; Fraser, G.E.; Goldbourt, U.; Heitmann, B.L.; Hallmans, G.; Liu, S.; et al. Antioxidant vitamins and coronary heart disease risk: A pooled analysis of 9 cohorts. Am. J. Clin. Nutr.？2004, 80, 1508–1520. 15585762
[3]
Kushi, L.H.; Folsom, A.R.; Prineas, R.J.; Mink, P.J.; Wu, Y.; Bostick, R.M. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N. Engl. J. Med.？1996, 334, 1156–1162.
[4]
Losonczy, K.G.; Harris, T.B.; Havlik, R.J. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The Established Populations for Epidemiologic Studies of the Elderly. Am. J. Clin. Nutr.？1996, 64, 190–196.
[5]
Rimm, E.B.; Stampfer, M.J.; Ascherio, A.; Giovannucci, E.; Colditz, G.A.; Willett, W.C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med.？1993, 328, 1450–1456.
[6]
Stampfer, M.J.; Hennekens, C.H.; Manson, J.E.; Colditz, G.A.; Rosner, B.; Willett, W.C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med.？1993, 328, 1444–1449.
[7]
WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): A major international collaboration. J. Clin. Epidemiol.？1988, 41, 105–114.
[8]
Blot, W.J.; Li, J.Y.; Taylor, P.R.; Guo, W.; Dawsey, S.; Wang, G.Q.; Yang, C.S.; Zheng, S.F.; Gail, M.; Li, G.Y.; et al. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst.？1993, 85, 1483–1492.
[9]
Virtamo, J.; Pietinen, P.; Huttunen, J.K.; Korhonen, P.; Malila, N.; Virtanen, M.J.; Albanes, D.; Taylor, P.R.; Albert, P. ATBC Study Group. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: A postintervention follow-up. J. Am. Med. Assoc.？2003, 290, 476–485.
[10]
GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardio). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet？1999, 354, 447–455. 10465168
[11]
Yusuf, S.; Dagenais, G.; Pogue, J.; Bosch, J.; Sleight, P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med.？2000, 342, 154–160. 10639540
[12]
Lonn, E.; Bosch, J.; Yusuf, S.; Sheridan, P.; Pogue, J.; Arnold, J.M.; Ross, C.; Arnold, A.; Sleight, P.; Probstfield, J.; Dagenais, G.R. HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: A randomized controlled trial. J. Am. Med. Assoc.？2005, 293, 1338–1347, doi:10.1001/jama.293.11.1338.
[13]
Hercberg, S.; Galan, P.; Preziosi, P.; Bertrais, S.; Mennen, L.; Malvy, D.; Roussel, A.M.; Favier, A.; Brian？on, S. The SU.VI.MAX Study: A randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch. Intern. Med.？2004, 164, 2335–2342, doi:10.1001/archinte.164.21.2335. 15557412
[14]
Lee, I.M.; Cook, N.R.; Gaziano, J.M.; Gordon, D.; Ridker, P.M.; Manson, J.E.; Hennekens, C.H.; Buring, J.E. Vitamin E in the primary prevention of cardiovascular disease and cancer: The Women's Health Study: A randomized controlled trial. J. Am. Med. Assoc.？2005, 294, 56–65.
[15]
Hennekens, C.H.; Buring, J.E.; Manson, J.E.; Stampfer, M.; Rosner, B.; Cook, N.R.; Belanger, C.; LaMotte, F.; Gaziano, J.M.; Ridker, P.M.; Willett, W.; Peto, R. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med.？1996, 334, 1145–1149.
[16]
Grodstein, F.; Kang, J.H.; Glynn, R.J.; Cook, N.R.; Gaziano, J.M. A randomized trial of beta carotene supplementation and cognitive function in men: The Physicians' Health Study II. Arch. Intern. Med.？2007, 167, 2184–2190.
[17]
Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss: Report No. 8. Arch. Ophthalmol.？2001, 119, 1417–1436. 11594942
[18]
Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta-carotene for age-related cataract and vision loss: Report No. 9. Arch. Ophthalmol.？2001, 119, 1439–1452. 11594943
[19]
Lippman, S.M.; Klein, E.A.; Goodman, P.J.; Lucia, M.S.; Thompson, I.M.; Ford, L.G.; Parnes, H.L.; Minasian, L.M.; Gaziano, J.M.; Hartline, J.A.; et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). J. Am. Med. Assoc.？2009, 301, 39–51.
[20]
Blumberg, J.B.; Frei, B. Why clinical trials of vitamin E and cardiovascular diseases may be fatally flawed. Commentary on "The relationship between dose of vitamin E and suppression of oxidative stress in humans". Free Radic. Biol. Med. ？2007, 43, 1374–1376, doi:10.1016/j.freeradbiomed.2007.08.017. 17936183
[21]
Dusting, G.J.; Triggle, C. Are we over oxidized? Oxidative stress, cardiovascular disease, and the future of intervention studies with antioxidants. Vasc. Health Risk Manag.？2005, 1, 93–97, doi:10.2147/vhrm.1.2.93.64080. 17315394
[22]
Heaney, R.P. Nutrients, endpoints, and the problem of proof. J. Nutr.？2008, 138, 1591–1595. 18716155
[23]
Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids; National Academy: Washington, DC, USA, 2000; p. 17.
[24]
Vivekananthan, D.P.; Penn, M.S.; Sapp, S.K.; Hsu, A.; Topol, E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: Meta-analysis of randomised trials. Lancet？2003, 361, 2017–2023.
[25]
Bjelakovic, G.; Nikolova, D.; Simonetti, R.G.; Gluud, C. Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis. Lancet？2004, 364, 1219–1228.
[26]
Miller, E.R., III; Pastor-Barriuso, R.; Dalal, D.; Riemersma, R.A.; Appel, L.A.; Guallar, E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med.？2005, 142, 37–46. 15537682
[27]
Bjelakovic, G.; Nikolova, D.; Gluud, L.L.; Simonetti, R.G.; Gluud, C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. J. Am. Med. Assoc.？2007, 297, 842–857.
[28]
Bjelakovic, G.; Nikolova, D.; Gluud, L.L.; Simonetti, R.G.; Gluud, C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev.？2008, 2, CD007176.
[29]
Chandra, R.K. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet？1992, 340, 1124–1127.
[30]
Smith, R. Research misconduct: The poisoning of the well. J. R. Soc. Med.？2006, 99, 232–237.
[31]
Bonelli, L.; Camoriano, A.; Ravelli, P.; Missale, G.; Bruzzi, P.; Aste, H. Reduction of the incidence of metachronous adenomas of the large bowel by means of antioxidants. In Proceedings of International Selenium Tellurium Development Association; Palmieri, Y., Ed.; Se-Te: Brussels, Belgium, 1998; pp. 91–94.
[32]
Sachs, L. Applied Statistics: A Handbook of Techniques (Springer Series in Statistics), 2nd ed.; Springer-Verlag: New York, NY, USA, 1984.
[33]
Girodon, F.; Lombard, M.; Galan, P.; Brunet-Lecomte, P.; Monget, A.L.; Arnaud, J.; Preziosi, P.; Hercberg, S. Effect of micronutrient supplementation on infection in institutionalized elderly subjects: A controlled trial. Ann. Nutr. Metab.？1997, 41, 98–107.
[34]
Girodon, F.; Galan, P.; Monget, A.L.; Boutron-Ruault, M.C.; Brunet-Lecomte, P.; Preziosi, P.; Arnaud, J.; Manuguerra, J.C.; Hercberg, S. MIN. VIT. AOX. geriatric network. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: A randomized controlled trial. Arch. Intern. Med.？1999, 159, 748–754, doi:10.1001/archinte.159.7.748. 10218756
[35]
Meydani, S.N.; Leka, L.S.; Fine, B.C.; Dallal, G.E.; Keusch, G.T.; Singh, M.F.; Hamer, D.H. Vitamin E and respiratory tract infections in elderly nursing home residents: A randomized controlled trial. J. Am. Med. Assoc.？2004, 292, 828–836.
[36]
Penn, N.D.; Purkins, L.; Kelleher, J.; Heatley, R.V.; Mascie-Taylor, B.H.; Belfield, P.W. The effect of dietary supplementation with vitamins A, C and E on cell-mediated immune function in elderly long-stay patients: A randomized controlled trial. Age Ageing？1991, 20, 169–174.
[37]
Pike, J.; Chandra, R.K. Effect of vitamin and trace element supplementation on immune indices in healthy elderly. Int. J. Vitam. Nutr. Res.？1995, 65, 117–121.
[38]
Gillilan, R.E.; Mondell, B.; Warbasse, J.R. Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am. Heart J.？1977, 93, 444–449.
[39]
McKeown-Eyssen, G.; Holloway, C.; Jazmaji, V.; Bright-See, E.; Dion, P.; Bruce, W.R. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res.？1988, 48, 4701–4705.
[40]
Greenberg, E.R.; Baron, J.A.; Stückel, T.A.; Stevens, M.M.; Mandel, J.S.; Spencer, S.K.; Elias, P.M.; Lowe, N.; Nierenberg, D.W.; Bayrd, G.; et al. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. N. Engl. J. Med.？1990, 323, 789–795. 2202901
[41]
Murphy, S.; West, K.P., Jr.; Greenough, W.B., III; Cherot, E.; Katz, J.; Clement, L. Impact of Vitamin A Supplementation on the Incidence of Infection in Elderly Nursing-home Residents: A Randomized Controlled Trial. Age Ageing？1992, 21, 435–439, doi:10.1093/ageing/21.6.435. 1471582
[42]
Li, J.Y.; Taylor, P.R.; Li, B.; Dawsey, S.; Wang, G.Q.; Ershow, A.G.; Guo, W.; Liu, S.F.; Yang, C.S.; Shen, Q.; et al. Nutrition Intervention Trials in Linxian, China: Multiple Vitamin/Mineral Supplementation, Cancer Incidence, and Disease-Specific Mortality Among Adults With Esophageal Dysplasia. J. Natl. Cancer Inst.？1993, 85, 1492–1498, doi:10.1093/jnci/85.18.1492. 8360932
[43]
Wenzel, G.; Kuklinski, B.; Rühlmann, C.; Ehrhardt, D. Alcohol-induced toxic hepatitis—a "free radical" associated disease. Lowering fatality by adjuvant antioxidant therapy. Z. Gesamte Inn. Med.？1993, 48, 490–496. 8256468
[44]
Greenberg, E.R.; Baron, J.A.; Tosteson, T.D.; Freeman, D.H., Jr.; Beck, G.J.; Bond, J.H.; Colacchio, T.A.; Coller, J.A.; Frankl, H.D.; Haile, R.W.; et al. A Clinical Trial of Antioxidant Vitamins to Prevent Colorectal Adenoma. N. Engl. J. Med.？1994, 331, 141–147.
[45]
Takamatsu, S.; Takamatsu, M.; Satoh, K.; Imaizumi, T.; Yoshida, H.; Hiramoto, M.; Koyama, M.; Ohgushi, Y.; Mizuno, S. Effects on health of dietary supplementation with 100 mg d-alpha-tocopheryl acetate, daily for 6 years. J. Int. Med. Res.？1995, 23, 342–357.
[46]
de la Maza, M.P.; Petermann, M.; Bunout, D.; Hirsch, S. Effects of long-term vitamin E supplementation in alcoholic cirrhotics. J. Am. Coll. Nutr.？1995, 14, 192–196.
[47]
ter Riet, G.; Kessels, A.G.; Knipschild, P.G. Randomized clinical trial of ascorbic acid in the treatment of pressure ulcers. J. Clin. Epidemiol.？1995, 48, 1453–1460.
[48]
Clark, L.C.; Combs, G.F., Jr.; Turnbull, B.W.; Slate, E.H.; Chalker, D.K.; Chow, J.; Davis, L.S.; Glover, R.A.; Graham, G.F.; Gross, E.G.; et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. J. Am. Med. Assoc.？1996, 276, 1957–1963.
[49]
Hogarth, M.B.; Marshall, P.; Lovat, L.B.; Palmer, A.J.; Frost, C.G.; Fletcher, A.E.; Nicholl, C.G.; Bulpitt, C.J. Nutritional supplementation in elderly medical in-patients: A double-blind placebo-controlled trial. Age Ageing？1996, 25, 453–457.
[50]
Richer, S. Multicenter ophthalmic and nutritional age-related macular degeneration study—part 2: Antioxidant intervention and conclusions. J. Am. Optom. Assoc.？1996, 67, 30–49.
[51]
Stephens, N.G.; Parsons, A.; Schofield, P.M.; Kelly, F.; Cheeseman, K.; Mitchinson, M.J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet？1996, 347, 781–786.
[52]
Moon, T.E.; Levine, N.; Cartmel, B.; Bangert, J.L.; Rodney, S.; Dong, Q.; Peng, Y.M.; Alberts, D.S. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: A randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol. Biomarkers Prev？1997, 6, 949–956. 9367069
[53]
Sano, M.; Ernesto, C.; Thomas, R.G.; Klauber, M.R.; Schafer, K.; Grundman, M.; Woodbury, P.; Growdon, J.; Cotman, C.W.; Pfeiffer, E.; Schneider, L.S.; Thal, L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's Disease. N. Engl. J. Med.？1997, 336, 1216–1222.
[54]
Green, A.; Williams, G.; Neale, R.; Hart, V.; Leslie, D.; Parsons, P.; Marks, G.C.; Gaffney, P.; Battistutta, D.; Frost, C.; et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: A randomised controlled trial. Lancet？1999, 354, 723–729. 10475183
[55]
Boaz, M.; Smetana, S.; Weinstein, T.; Matas, Z.; Gafter, U.; Iaina, A.; Knecht, A.; Weissgarten, Y.; Brunner, D.; Fainaru, M.; Green, M.S. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial. Lancet？2000, 356, 1213–1218.
[56]
Correa, P.; Fontham, E.T.; Bravo, J.C.; Bravo, L.E.; Ruiz, B.; Zarama, G.; Realpe, J.L.; Malcom, G.T.; Li, D.; Johnson, W.D.; Mera, R. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J. Natl. Cancer Inst.？2000, 92, 1881–1888.
[57]
Jacobson, J.S.; Begg, M.D.; Wang, L.W.; Wang, Q.; Agarwal, M.; Norkus, E.; Singh, V.N.; Young, T.L.; Yang, D.; Santella, R.M. Effects of a 6-month vitamin intervention on DNA damage in heavy smokers. Cancer Epidemiol. Biomarkers Prev.？2000, 9, 1303–1311.
[58]
Brown, B.G.; Zhao, X.Q.; Chait, A.; Fisher, L.D.; Cheung, M.C.; Morse, J.S.; Dowdy, A.A.; Marino, E.K.; Bolson, E.L.; Alaupovic, P.; et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N. Engl. J. Med.？2001, 345, 1583–1592. 11757504
[59]
Desnuelle, C.; Dib, M.; Garrel, C.; Favier, A. ALS riluzole-tocopherol Study Group. A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord.？2001, 2, 9–18, doi:10.1080/146608201300079364. 11465936
[60]
Stevic, Z.; Nicolic, A.; Blagjevic, D.; Saicia, Z.S.; Kocev, N.; Apostolski, S.; Spasi？, M.B. A controlled trial of combination of methionine and antioxidants in ALS patients. Jugoslov. Med. Biochem.？2001, 20, 223–228.
[61]
You, W.C.; Chang, Y.S.; Heinrich, J.; Ma, J.L.; Liu, W.D.; Zhang, L.; Brown, L.M.; Yang, C.S.; Gail, M.H.; Fraumeni, J.F., Jr.; Xu, G.W. An intervention trial to inhibit the progression of precancerous gastric lesions: Compliance, serum micronutrients and S-allyl cysteine levels, and toxicity. Eur. J. Cancer Prev.？2001, 10, 257–263, doi:10.1097/00008469-200106000-00009. 11432713
[62]
de Gaetano, G. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice. Lancet？2001, 357, 89–95.
[63]
de Waart, F.G.; Kok, F.J.; Smilde, T.J.; Hijmans, A.; Wollersheim, H.; Stalenhoef, A.F. Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers. Atherosclerosis？2001, 158, 227–231.
[64]
Chylack, L.T., Jr.; Brown, N.P.; Bron, A.; Hurst, M.; K？pcke, W.; Thien, U.; Schalch, W. The Roche European American Cataract Trial (REACT): A randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol.？2002, 9, 49–80.
[65]
Graat, J.M.; Schouten, E.G.; Kok, F.J. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: A randomized controlled trial. J. Am. Med. Assoc.？2002, 288, 715–721.
[66]
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: A randomised placebo-controlled trial. Lancet？2002, 360, 23–33.
[67]
Hodis, H.N.; Mack, W.J.; LaBree, L.; Mahrer, P.R.; Sevanian, A.; Liu, C.R.; Liu, C.H.; Hwang, J.; Selzer, R.H.; Azen, S.P. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: The Vitamin E Atherosclerosis Prevention Study. Circulation？2002, 106, 1453–1459.
[68]
Waters, D.D.; Alderman, E.L.; Hsia, J.; Howard, B.V.; Cobb, F.R.; Rogers, W.J.; Ouyang, P.; Thompson, P.; Tardif, J.C.; Higginson, L.; et al. Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women: A Randomized Controlled Trial. J. Am. Med. Assoc.？2002, 288, 2432–2440.
[69]
White, K.L.; Chalmers, D.M.; Martin, I.G.; Everett, S.M.; Neville, P.M.; Naylor, G.; Sutcliffe, A.E.; Dixon, M.F.; Turner, P.C.; Schorah, C.J. Dietary antioxidants and DNA damage in patients on long-term acid-suppression therapy: A randomized controlled study. Br. J. Nutr.？2002, 88, 265–271.
[70]
Wluka, A.E.; Stuckey, S.; Brand, C.; Cicuttini, F.M. Supplementary vitamin E does not affect the loss of cartilage volume in knee osteoarthritis: A 2 year double blind randomized placebo controlled study. J. Rheumatol.？2002, 29, 2585–2591.
[71]
Collins, E.G.; Edwin Langbein, W.; Orebaugh, C.; Bammert, C.; Hanson, K.; Reda, D.; Edwards, L.C.; Littooy, F.N. PoleStriding exercise and vitamin E for management of peripheral vascular disease. Med. Sci. Sports Exerc.？2003, 35, 384–393.
[72]
Prince, M.I.; Mitchison, H.C.; Ashley, D.; Burke, D.A.; Edwards, N.; Bramble, M.G.; James, O.F.; Jones, D.E. Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: Results of a multicentre, randomized, placebo-controlled, cross-over trial. Aliment. Pharmacol. Ther.？2003, 17, 137–143. 12492743
[73]
Salonen, R.M.; Nyyss？nen, K.; Kaikkonen, J.; Porkkala-Sarataho, E.; Voutilainen, S.; Rissanen, T.H.; Tuomainen, T.P.; Valkonen, V.P.; Ristonmaa, U.; Lakka, H.M.; et al. Six-Year Effect of Combined Vitamin C and E Supplementation on Atherosclerotic Progression: The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation？2003, 107, 947–953. 12600905
[74]
Sasazuki, S.; Sasaki, S.; Tsubono, Y.; Okubo, S.; Hayashi, M.; Kakizoe, T.; Tsugane, S. The effect of 5-year vitamin C supplementation on serum pepsinogen level and Helicobacter pylori infection. Cancer Sci.？2003, 94, 378–382.
[75]
Takagi, H.; Kakizaki, S.; Sohara, N.; Sato, K.; Tsukioka, G.; Tago, Y.; Konaka, K.; Kabeya, K.; Kaneko, M.; Takayama, H.; et al. Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis. Int. J. Vitam. Nutr. Res.？2003, 73, 411–415, doi:10.1024/0300-9831.73.6.411. 14743544
[76]
Allsup, S.J.; Shenkin, A.; Gosney, M.A.; Taylor, S.; Taylor, W.; Hammond, M.; Zambon, M.C. Can a short period of micronutrient supplementation in older institutionalized people improve response to influenza vaccine? A randomized, controlled trial. J. Am. Geriatr. Soc.？2004, 52, 20–24.
[77]
Goodman, G.E.; Thornquist, M.D.; Balmes, J.; Cullen, M.R.; Meyskens, F.L., Jr.; Omenn, G.S.; Valanis, B.; Williams, J.H., Jr. The Beta-Carotene and Retinol Efficacy Trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J. Natl. Cancer Inst.？2004, 96, 1743–1750, doi:10.1093/jnci/djh320. 15572756
[78]
Manuel-Y-Keenoy, B.; Vinckx, M.; Vertommen, J.; van Gaal, L.; de Leeuw, I. Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin. Atherosclerosis？2004, 175, 369–376.
Mezey, E.; Potter, J.J.; Rennie-Tankersley, L.; Caballeria, J.; Pares, A. A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J. Hepatol.？2004, 40, 40–46.
[81]
Richer, S.; Stiles, W.; Statkute, L.; Pulido, J.; Frankowski, J.; Rudy, D.; Pei, K.; Tsipursky, M.; Nyland, J. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: The Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry？2004, 75, 216–230.
[82]
Avenell, A.; Campbell, M.K.; Cook, J.A.; Hannaford, P.C.; Kilonzo, M.M.; McNeill, G.; Milne, A.C.; Ramsay, C.R.; Seymour, D.G.; Stephen, A.I.; Vale, L.D. Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): Pragmatic, randomised, double blind, placebo controlled trial. Br. Med. J.？2005, 331, 324–329.
[83]
Graf, M.; Ecker, D.; Horowski, R.; Kramer, B.; Riederer, P.; Gerlach, M.; Hager, C.; Ludolph, A.C.; Becker, G.; Osterhage, J.; et al. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: Results of a placebo-controlled double-blind study. J. Neural Transm.？2005, 112, 649–660, doi:10.1007/s00702-004-0220-1. 15517433
[84]
Limburg, P.J.; Wei, W.; Ahnen, D.J.; Qiao, Y.; Hawk, E.T.; Wang, G.; Giffen, C.A.; Wang, G.; Roth, M.J.; Lu, N.; et al. Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology？2005, 129, 863–873. 16143126
[85]
Marras, C.; McDermott, M.P.; Rochon, P.A.; Tanner, C.M.; Naglie, G.; Rudolph, A.; Lang, A.E. Parkinson Study Group. Survival in Parkinson disease: Thirteen-year follow-up of the DATATOP cohort. Neurology？2005, 64, 87–93, doi:10.1212/01.WNL.0000148603.44618.19. 15642909
[86]
Mooney, L.A.; Madsen, A.M.; Tang, D.; Orjuela, M.A.; Tsai, W.Y.; Garduno, E.R.; Perera, F.P. Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers. Cancer Epidemiol. Biomarkers Prev.？2005, 14, 237–242.
[87]
Petersen, R.C.; Thomas, R.G.; Grundman, M.; Bennett, D.; Doody, R.; Ferris, S.; Galasko, D.; Jin, S.; Kaye, J.; Levey, A.; et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med.？2005, 352, 2379–2388, doi:10.1056/NEJMoa050151. 15829527
[88]
Tam, L.S.; Li, E.K.; Leung, V.Y.; Griffith, J.F.; Benzie, I.F.; Lim, P.L.; Whitney, B.; Lee, V.W.; Lee, K.K.; Thomas, G.N.; Tomlinson, B. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: A double blind, placebo controlled pilot study. J. Rheumatol.？2005, 32, 275–282.
[89]
Witte, K.K.; Nikitin, N.P.; Parker, A.C.; von Haehling, S.; Volk, H.D.; Anker, S.D.; Clark, A.L.; Cleland, J.G. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur. Heart J.？2005, 26, 2238–2244.
[90]
Rayman, M.; Thompson, A.; Warren-Perry, M.; Galassini, R.; Catterick, J.; Hall, E.; Lawrence, D.; Bliss, J. Impact of selenium on mood and quality of life: A randomized, controlled trial. Biol. Psychiatry？2006, 59, 147–154.
[91]
Li, H.; Kantoff, P.W.; Giovannucci, E.; Leitzmann, M.F.; Gaziano, J.M.; Stampfer, M.J.; Ma, J. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res.？2005, 65, 2498–2504. 15781667
[92]
Berry, D.; Wathen, J.K.; Newell, M. Bayesian model averaging in meta-analysis: Vitamin E supplementation and mortality. Clin. Trials？2009, 6, 28–41.
[93]
Watters, J.L.; Gail, M.H.; Weinstein, S.J.; Virtamo, J.; Albanes, D. Associations between α-tocopherol, β-carotene, and retinol and prostate cancer survival. Cancer Res.？2009, 69, 3833–3841, doi:10.1158/0008-5472.CAN-08-4640. 19383902
[94]
Milman, U.; Blum, S.; Shapira, C.; Aronson, D.; Miller-Lotan, R.; Anbinder, Y.; Alshiek, J.; Bennett, L.; Kostenko, M.; Landau, M.; et al. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: A prospective double-blinded clinical trial. Arterioscler. Thromb. Vasc. Biol.？2008, 28, 341–347. 18032779
[95]
Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids; National Academy: Washington, DC, USA, 2000; pp. 73–94.
